Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Cancer Cachexia to Musculoskeletal Disorders Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Cancer Cachexia to Musculoskeletal Disorders Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Cancer Cachexia Therapeutics Clinical Trials 27
Prominent Drugs 28
Clinical Trial Profile Snapshots 29
Appendix 76
Abbreviations 76
Definitions 76
Research Methodology 77
Secondary Research 77
About GlobalData 78
Contact Us 78
Disclaimer 78
Source 79
Cancer Cachexia Therapeutics, Global, Clinical Trials by Region, 2016* 6
Cancer Cachexia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Cancer Cachexia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Cancer Cachexia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9
Cancer Cachexia Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10
Cancer Cachexia Therapeutics Clinical Trials, North America, Top Countries, 2016* 11
Cancer Cachexia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 12
Cancer Cachexia Therapeutics Clinical Trials, Central and South America, Top Countries, 2016* 13
Proportion of Cancer Cachexia to Musculoskeletal Disorders Clinical Trials, G7 Countries (%), 2016* 14
Cancer Cachexia Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
Cancer Cachexia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
Proportion of Cancer Cachexia to Musculoskeletal Disorders Clinical Trials, E7 Countries (%), 2016* 17
Cancer Cachexia Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
Cancer Cachexia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19
Cancer Cachexia Therapeutics, Global, Clinical Trials by Phase, 2016* 20
Cancer Cachexia Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 21
Cancer Cachexia Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
Cancer Cachexia Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
Cancer Cachexia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
Cancer Cachexia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 25
Cancer Cachexia Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
Cancer Cachexia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27
Cancer Cachexia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28
List of Figures
Cancer Cachexia Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
Cancer Cachexia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Cancer Cachexia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Cancer Cachexia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 9
Cancer Cachexia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10
Cancer Cachexia Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11
Cancer Cachexia Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2016* 12
Proportion of Cancer Cachexia to Musculoskeletal Disorders Clinical Trials, G7 Countries (%), 2016* 14
Cancer Cachexia Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
Cancer Cachexia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
Proportion of Cancer Cachexia to Musculoskeletal Disorders Clinical Trials, E7 Countries (%), 2016* 17
Cancer Cachexia Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
Cancer Cachexia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19
Cancer Cachexia Therapeutics, Global, Clinical Trials by Phase (%), 2016* 20
Cancer Cachexia Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 21
Cancer Cachexia Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
Cancer Cachexia Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
Cancer Cachexia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
Cancer Cachexia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 25
Cancer Cachexia Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
Cancer Cachexia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27
Cancer Cachexia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28
GlobalData Methodology 77
【掲載企業】
GTx, Inc.
Helsinn Holding S.A.
Medpace, Inc.
Novartis AG
XBiotech USA, Inc.
Ono Pharmaceutical Co., Ltd.
Ohr Pharmaceutical Inc.
Merck & Co., Inc.
Ark Therapeutics Limited
Aeterna Zentaris Inc.
【レポートのキーワード】
がん悪液質(Cancer Cachexia)、治験、臨床試験、治験、治療薬